Nilo Therapeutics is an early-stage biotech company developing groundbreaking therapies for autoimmune and inflammatory diseases. Our experienced team brings together diverse interdisciplinary expertise to modulate immune responses via activation of neural circuits. United by our passion for discovering and translating novel biology, we are dedicated to advancing human health through transformative science.
Company Details
- Employees
- 24
- Founded
- 2024
- Address
- New York City, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- New York City
Nilo Therapeutics Questions
Nilo Therapeutics's LinkedIn profile is https://www.linkedin.com/company/nilo-therapeutics
Nilo Therapeutics has
24 employees.
View email and phone details for 24
employees at Nilo Therapeutics.
Nilo Therapeutics's industry is
Biotechnology Research
Nilo Therapeutics's top competitors are
Anavex Life Sciences,
Jung+ Longevity,
Corxel Pharmaceuticals,
Protara Therapeutics,
Evolveimmune Therapeutics,
Invitro Cell Research, Llc,
Kallyope,
Caladan Bio,
Princeton Biopartners,
Neptune Bio.
Nilo Therapeutics's categories are Biotechnology Research
Nilo Therapeutics's founding year is 2024
